IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 174 filers reported holding IMPAX LABORATORIES INC in Q2 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $52,296,000 | +5.4% | 2,688,756 | -9.8% | 0.02% | +4.8% |
| Q4 2017 | $49,618,000 | -18.1% | 2,979,998 | -0.1% | 0.02% | -19.2% |
| Q3 2017 | $60,577,000 | +16.0% | 2,983,964 | -8.0% | 0.03% | +8.3% |
| Q2 2017 | $52,238,000 | +56.6% | 3,244,580 | +23.0% | 0.02% | +50.0% |
| Q1 2017 | $33,359,000 | +40.5% | 2,637,077 | +47.2% | 0.02% | +33.3% |
| Q4 2016 | $23,739,000 | -37.3% | 1,791,702 | +12.2% | 0.01% | -40.0% |
| Q3 2016 | $37,849,000 | -19.8% | 1,597,008 | -2.5% | 0.02% | -25.9% |
| Q2 2016 | $47,207,000 | -5.0% | 1,637,942 | +5.5% | 0.03% | -10.0% |
| Q1 2016 | $49,699,000 | -22.3% | 1,552,088 | +3.8% | 0.03% | -25.0% |
| Q4 2015 | $63,933,000 | +20.7% | 1,495,098 | -0.6% | 0.04% | +14.3% |
| Q3 2015 | $52,982,000 | -27.3% | 1,504,854 | -5.1% | 0.04% | -22.2% |
| Q2 2015 | $72,848,000 | -3.1% | 1,586,394 | -1.1% | 0.04% | -4.3% |
| Q1 2015 | $75,173,000 | +59.0% | 1,603,880 | +7.5% | 0.05% | +51.6% |
| Q4 2014 | $47,267,000 | +39.8% | 1,491,963 | +4.6% | 0.03% | +29.2% |
| Q3 2014 | $33,805,000 | -21.2% | 1,425,704 | -0.3% | 0.02% | -20.0% |
| Q2 2014 | $42,895,000 | +17.5% | 1,430,292 | +3.5% | 0.03% | +11.1% |
| Q1 2014 | $36,507,000 | +20.6% | 1,381,862 | +14.7% | 0.03% | +12.5% |
| Q4 2013 | $30,278,000 | +38.8% | 1,204,414 | +13.3% | 0.02% | +26.3% |
| Q3 2013 | $21,810,000 | +20.3% | 1,063,447 | +17.0% | 0.02% | +11.8% |
| Q2 2013 | $18,127,000 | – | 908,641 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|